Dr. Wheeler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Advanced Heart Failure and Transplant Cardiology, 2012 - 2013
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2007 - 2012
- Stanford Health CarePost-Doctoral Fellowship, 2007 - 2008
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2005 - 2007
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2007 - 2024
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Study of Exercise Training in Hypertrophic Cardiomyopathy Start of enrollment: 2010 Apr 01
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM Start of enrollment: 2014 Mar 01
- A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 91 citationsMolecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise.James A. Sanford, Christopher D. Nogiec, Malene E. Lindholm, Joshua N. Adkins, David Amar
Cell. 2020-06-25 - 19 citationsPathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure.Pablo Cordero, Victoria N. Parikh, Elizabeth T Chin, Ayca Erbilgin, Michael J. Gloudemans
Nature Communications. 2019-06-24 - 445 citationsMavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P. Abraham, Ahmad Masri
Lancet. 2020-09-12
Journal Articles
- Effect of Genetic Diagnosis on Patients with Previously Undiagnosed DiseaseCarlos A Bacino, Vandana Shashi, Euan A Ashley, Cynthia J Tifft, William A Gahl, Brendan H Lee, John J Mulvihill, Rizwan Hamid, Matthew T Wheeler, Jonathan A Bernstein..., The New England Journal of Medicine
- Original Investigation Editorial Comment Genome Sequencing in Hypertrophic Cardiomyopathy∗Euan A Ashley, Matthew T Wheeler, Chloe M Reuter, ScienceDirect
Press Mentions
- Intellia, with First Results, Delivers a 'Landmark' for CRISPR Gene EditingJune 26th, 2021
- Fitness Trackers Accurately Measure Heart Rate but Not Calories BurnedMay 24th, 2017
- DCM Precision Medicine StudyJanuary 31st, 2017
Grant Support
- GREGoR Stanford SiteNHGRI2021–Present
- Center for Undiagnosed Diseases at Stanford U01NINDS2014–Present
Professional Memberships
- Member
- American Society of Human GeneticsMember
External Links
- Stanford Center for Inherited Cardiovascular Diseasehttp://familyheart.stanford.edu/
- Stanford Amyloid Centerhttp://stanfordhealthcare.org/medical-clinics/amyloid-center.html
- Stanford Program in Mechanical Circulatory Supporthttps://stanfordhealthcare.org/programs-services/mechanical-circulatory-support.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: